RE:RE:RE:RE:RE:RE:Get ready for more merger mania in the pharma sector If a buyout is contemplated, existing share price means nothing. If ONC's board votes to bring a BP offer to shareholders, the sale price per share will be the BP purchase price divided by the outstanding shares (plus exercised options and warrants). There would be no need to find a mechanism to ramp up the existing market share price.
The above is a "friendly takeover" scenario. If it is a hostile takeover (the ONC BOD chooses not to recommend that shareholders tender their shares to the prospective buyer) then the buyer would have to find a price that's attractive to enough existing shareholders that they can accumulate enough shares to get effective control of the company. We all have our trigger price . . .